August 2018 PBAC special meeting - Invitation for submissions open and background paper available

PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types

Page last updated: 21 May 2018

The invitation for submissions to the August 2018 PBAC special meeting regarding PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types, is now open, closing 5pm AEST 29 June 2018. Submissions must be made in writing and emailed to the PBAC Secretariat.

Further information is available on the August 2018 PBAC special meeting page.